How Much Is the Wegovy Injection in the UK?

How UK private Wegovy pricing is structured

NICE recommended semaglutide (Wegovy) for weight management in March 2023 under NICE technology appraisal TA875, and the injection has been available privately in the UK for longer than that. Private pricing here is not set by any single authority: each provider sets its own, and what looks like an apples-to-apples comparison rarely is. Prices are generally quoted per pen per month, and Eli Lilly's September 2025 list-price increase for Mounjaro prompted broader market-wide price recalibration, Wegovy pricing shifted in response too, with typical private costs landing roughly between £149 and £375 per month depending on the dose and the service.

The dose matters because it changes throughout treatment. The standard titration schedule runs 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with step-ups approximately every four weeks under prescriber guidance. Lower-dose pens are generally cheaper; the maintenance dose is the most expensive. If you are trying to understand how much Wegovy injections are likely to cost you across the full titration, it is worth asking which dose any headline figure reflects. You can read more about how Wegovy injection pricing maps across different doses if you want a fuller breakdown.

In the STEP 1 trial, published in the New England Journal of Medicine, adults treated with semaglutide 2.4 mg lost an average of around 15% of their body weight over 68 weeks alongside lifestyle changes. That evidence base is what underpins the licence, not a social media trend, not a celebrity endorsement. For a medicine with that kind of clinical record, the wegovy injection cost question is really about what a particular service is offering around the medicine, not just the medicine itself.

What headline prices frequently leave out

A number posted on a provider's homepage is not always what you will pay at checkout. Several types of charge regularly appear as extras: an initial consultation fee, a prescription-writing charge, a delivery fee per order, and a cost for any clinical aftercare calls you need between pens. Add those up over a titration period and the gap between a low headline figure and a genuinely all-in price can close considerably.

There is also the question of what happens when your dose increases. Some services require a fresh assessment (and a fresh charge) at each step. Others bundle dose-change reviews into the ongoing service. Clinical aftercare is not a nice-to-have for a prescription medicine; the NHS guidance on semaglutide is clear that dosing decisions should be made with a healthcare professional, not independently. A service that makes aftercare easy and free is worth more than one that makes it an obstacle.

It is also worth knowing that Wegovy is now approved in the UK in a 7.2 mg dose, initially supplied as three 2.4 mg pens weekly, then later as a dedicated single-dose pen approved by the MHRA on 14 April 2026. Not every provider stocks every format; confirming availability before you commit matters. Our detailed guide to Wegovy injections cost, including how pricing shifts as formats change, gives you a clearer picture of what to budget for at each stage.

The nume position: transparent, all-in, not the cheapest

We are not going to win a race to the lowest price. That is a deliberate choice. A single, transparent price at nume covers the clinical consultation, the prescription, the treatment itself, and next-working-day DPD delivery, all in. No line items added later, no subscription that renews automatically, no consultation fee that appears only once you try to place your first repeat order. Every repeat order is clinically re-reviewed before it goes out; dose increases require evidence, not just a request.

When your pen arrives, it comes in plain, unbranded packaging via DPD with a tracking link so you know exactly when to expect it. There is nothing on the outside to indicate what is inside. The clinical work happens before dispatch: every consultation is read by a GPhC-registered Independent Prescriber the same day, and you can learn more about the clinical team who do that reviewing.

For a fuller picture of how our service compares to what the private market offers, the semaglutide injection price guide lays out the context clearly. And if you want to see what current treatment pricing looks like at nume specifically, the treatment page has everything in one place.

Why 'cheapest' is the wrong question to ask about a prescription medicine

The MHRA has warned repeatedly about fake weight-loss pens sold online and via social media. In October 2023 the regulator issued a public warning about counterfeit semaglutide and liraglutide pens; enforcement has escalated significantly since, with roughly 20 million doses of illegally traded weight-loss medicines (around £45 million in street value) seized, and the first illicit UK manufacturing site producing fake tirzepatide pens raided in October 2025. Some counterfeit pens have contained insulin. You can report a suspected fake seller directly through the MHRA's Yellow Card scheme.

The pattern these cases share is consistent: prices far below the private market, sellers operating without a verifiable registered pharmacy, and offers that bypass the clinical assessment a prescription medicine legally requires. A deeply discounted price for a POM is not a saving. It is a red flag. You can verify any UK online pharmacy against the GPhC register in a few seconds; if a seller is not on it, do not buy from them regardless of price.

The right question is not which provider is cheapest. It is which provider gives you a genuine medicine, from the licensed supply chain, reviewed by a real clinician, supported if something goes wrong. If you have more questions about how the service works, our FAQs cover the most common ones, or you can start your free consultation today.